Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Oxford Gene Technology
Oxford Gene Technology
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Pharmaceutical
Cytocell operations move to Cambridge Science Park
Growth of the Oxford Gene Technology's brand has lead to an investment in expanding the production capacity to meet demand
Regulatory
Oxford Gene Technology announces organisational changes
Analysis
OGT pushes forward hybridisation-based targeted sequencing
OGT’s hybridisation expertise takes researchers from sample to sequencer in a single day
Analysis
OGT expands Cytocell sarcoma FISH probe range
Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its range of Cytocell Aquarius fluorescence in situ hybridisation (FISH) probes for pathology
Research & Development
Oxford Gene Technology to purchase Cytocell
Underscores commitment to become a global leader in genomic medicine
Pharmaceutical
OGT develops biomarker panel to support earlier SLE diagnosis
The panel is said to have superior sensitivity and specificity compared to current laboratory tests
Research & Development
OGT expands commitment to improved cancer profiling with CCMC agreement
Will design a whole genome, cancer-specific microarray
Subscribe now